Cargando…

Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer

SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravalet, Noémie, Foucault, Amélie, Picou, Frédéric, Gombert, Martin, Renoult, Emmanuel, Lejeune, Julien, Vallet, Nicolas, Lachot, Sébastien, Rault, Emmanuelle, Gyan, Emmanuel, Bene, Marie C., Herault, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865695/
https://www.ncbi.nlm.nih.gov/pubmed/33494332
http://dx.doi.org/10.3390/cancers13030389
_version_ 1783647906926952448
author Ravalet, Noémie
Foucault, Amélie
Picou, Frédéric
Gombert, Martin
Renoult, Emmanuel
Lejeune, Julien
Vallet, Nicolas
Lachot, Sébastien
Rault, Emmanuelle
Gyan, Emmanuel
Bene, Marie C.
Herault, Olivier
author_facet Ravalet, Noémie
Foucault, Amélie
Picou, Frédéric
Gombert, Martin
Renoult, Emmanuel
Lejeune, Julien
Vallet, Nicolas
Lachot, Sébastien
Rault, Emmanuelle
Gyan, Emmanuel
Bene, Marie C.
Herault, Olivier
author_sort Ravalet, Noémie
collection PubMed
description SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags occur upon complete blood count (CBC). Consequently, the suspicion of MDS can be delayed in the absence of systematic blood smear observation, which is crucial to initiate a full diagnosis process by cytological analysis of bone marrow aspiration. The Beckman Coulter DxH 800 hematology analyzer (Beckman-Coulter, Brea, CA) is widely used over the world. We propose in this study the clinical use of 10 unexploited “research parameters” for early detection of subclinical MDS by selective triggering of blood smear examination. ABSTRACT: The incidence of myelodysplastic syndrome increases with aging and the early diagnosis enables optimal care of these diseases. The DxH 800 hematology analyzer measures and calculates 126 cytological parameters, but only 23 are used for routine CBC assessment. The goal of this study was to use the 103 unexploited “research parameters” to develop an algorithm allowing for an early detection of subclinical MDS patients by triggering morphological analysis. Blood sample parameters from 101 MDS patients and 88 healthy volunteers were analyzed to identify the critical “research parameters” with: (i) the most significant differences between MDS patients and healthy volunteers, (ii) the best contributions to principal component analysis (PCA), first axis, and (iii) the best correlations with PCA, first two axes (cos(2) > 0.6). Ten critical “research parameters” of white blood cells were identified, allowing for the calculation of an MDS-likelihood score (MDS-LS), based on logistic regression. Automatic calculation of the MDS-LS is easily implementable on the middleware system of the DxH 800 to generate a flag for blood smear review, and possibly early detection of MDS patients in the general population.
format Online
Article
Text
id pubmed-7865695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78656952021-02-07 Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer Ravalet, Noémie Foucault, Amélie Picou, Frédéric Gombert, Martin Renoult, Emmanuel Lejeune, Julien Vallet, Nicolas Lachot, Sébastien Rault, Emmanuelle Gyan, Emmanuel Bene, Marie C. Herault, Olivier Cancers (Basel) Article SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags occur upon complete blood count (CBC). Consequently, the suspicion of MDS can be delayed in the absence of systematic blood smear observation, which is crucial to initiate a full diagnosis process by cytological analysis of bone marrow aspiration. The Beckman Coulter DxH 800 hematology analyzer (Beckman-Coulter, Brea, CA) is widely used over the world. We propose in this study the clinical use of 10 unexploited “research parameters” for early detection of subclinical MDS by selective triggering of blood smear examination. ABSTRACT: The incidence of myelodysplastic syndrome increases with aging and the early diagnosis enables optimal care of these diseases. The DxH 800 hematology analyzer measures and calculates 126 cytological parameters, but only 23 are used for routine CBC assessment. The goal of this study was to use the 103 unexploited “research parameters” to develop an algorithm allowing for an early detection of subclinical MDS patients by triggering morphological analysis. Blood sample parameters from 101 MDS patients and 88 healthy volunteers were analyzed to identify the critical “research parameters” with: (i) the most significant differences between MDS patients and healthy volunteers, (ii) the best contributions to principal component analysis (PCA), first axis, and (iii) the best correlations with PCA, first two axes (cos(2) > 0.6). Ten critical “research parameters” of white blood cells were identified, allowing for the calculation of an MDS-likelihood score (MDS-LS), based on logistic regression. Automatic calculation of the MDS-LS is easily implementable on the middleware system of the DxH 800 to generate a flag for blood smear review, and possibly early detection of MDS patients in the general population. MDPI 2021-01-21 /pmc/articles/PMC7865695/ /pubmed/33494332 http://dx.doi.org/10.3390/cancers13030389 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ravalet, Noémie
Foucault, Amélie
Picou, Frédéric
Gombert, Martin
Renoult, Emmanuel
Lejeune, Julien
Vallet, Nicolas
Lachot, Sébastien
Rault, Emmanuelle
Gyan, Emmanuel
Bene, Marie C.
Herault, Olivier
Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title_full Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title_fullStr Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title_full_unstemmed Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title_short Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
title_sort automated early detection of myelodysplastic syndrome within the general population using the research parameters of beckman–coulter dxh 800 hematology analyzer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865695/
https://www.ncbi.nlm.nih.gov/pubmed/33494332
http://dx.doi.org/10.3390/cancers13030389
work_keys_str_mv AT ravaletnoemie automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT foucaultamelie automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT picoufrederic automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT gombertmartin automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT renoultemmanuel automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT lejeunejulien automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT valletnicolas automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT lachotsebastien automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT raultemmanuelle automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT gyanemmanuel automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT benemariec automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer
AT heraultolivier automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer